HK1248589A1 - 柠檬酸铁在治疗缺铁性贫血中的用途 - Google Patents

柠檬酸铁在治疗缺铁性贫血中的用途 Download PDF

Info

Publication number
HK1248589A1
HK1248589A1 HK18108472.0A HK18108472A HK1248589A1 HK 1248589 A1 HK1248589 A1 HK 1248589A1 HK 18108472 A HK18108472 A HK 18108472A HK 1248589 A1 HK1248589 A1 HK 1248589A1
Authority
HK
Hong Kong
Prior art keywords
iron
ferric citrate
months
certain embodiments
subject
Prior art date
Application number
HK18108472.0A
Other languages
English (en)
Chinese (zh)
Inventor
恩里克‧普拉多苏
恩裡克‧普拉多蘇
谢伊‧大卫‧谢梅什
罗恩‧本图尔
謝伊‧大衛‧謝梅什
羅恩‧本圖爾
Original Assignee
凯克斯生物制药公司
凱克斯生物製藥公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 凯克斯生物制药公司, 凱克斯生物製藥公司 filed Critical 凯克斯生物制药公司
Publication of HK1248589A1 publication Critical patent/HK1248589A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK18108472.0A 2015-03-04 2016-03-03 柠檬酸铁在治疗缺铁性贫血中的用途 HK1248589A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562127963P 2015-03-04 2015-03-04
US62/127,963 2015-03-04
PCT/US2016/020575 WO2016141124A1 (en) 2015-03-04 2016-03-03 Use of ferric citrate in the treatment of iron-deficiency anemia

Publications (1)

Publication Number Publication Date
HK1248589A1 true HK1248589A1 (zh) 2018-10-19

Family

ID=56848619

Family Applications (2)

Application Number Title Priority Date Filing Date
HK18108472.0A HK1248589A1 (zh) 2015-03-04 2016-03-03 柠檬酸铁在治疗缺铁性贫血中的用途
HK18106104.0A HK1246649A1 (zh) 2015-03-04 2016-03-03 柠檬酸铁在治疗缺铁性贫血中的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18106104.0A HK1246649A1 (zh) 2015-03-04 2016-03-03 柠檬酸铁在治疗缺铁性贫血中的用途

Country Status (15)

Country Link
US (2) US20180071243A1 (cg-RX-API-DMAC7.html)
EP (1) EP3265077A4 (cg-RX-API-DMAC7.html)
JP (2) JP2018507260A (cg-RX-API-DMAC7.html)
KR (1) KR20170123664A (cg-RX-API-DMAC7.html)
CN (1) CN107530310A (cg-RX-API-DMAC7.html)
AU (1) AU2016226250B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017018963A2 (cg-RX-API-DMAC7.html)
CA (1) CA2978073A1 (cg-RX-API-DMAC7.html)
EA (1) EA201791960A1 (cg-RX-API-DMAC7.html)
HK (2) HK1248589A1 (cg-RX-API-DMAC7.html)
IL (1) IL254125A0 (cg-RX-API-DMAC7.html)
MX (1) MX2017011169A (cg-RX-API-DMAC7.html)
SG (1) SG11201707120PA (cg-RX-API-DMAC7.html)
TW (2) TW202302083A (cg-RX-API-DMAC7.html)
WO (1) WO2016141124A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120046753A (ko) 2009-07-21 2012-05-10 케릭스 바이오파마슈티컬스 인코포레이티드 구연산철 투여형태
US20210085711A1 (en) * 2017-09-19 2021-03-25 Japan Tobacco Inc. Use of ferric citrate in prevention and/or treatment of iron-deficiency anemia in hypermenorrhea patient and/or patient suffering from hypermenorrhea-associated gynecologic disease
FR3075601A1 (fr) * 2017-12-21 2019-06-28 Clarisse Le Court Complements alimentaires et leur utilisation sur les menstruations
US12467933B2 (en) 2019-06-07 2025-11-11 Arizona Board Of Regents On Behalf Of Arizona State University Body fluid iron level panel analyzer
EP4347022A1 (en) 2021-05-27 2024-04-10 Keryx Biopharmaceuticals, Inc. Pediatric formulations of ferric citrate
WO2023047424A1 (en) * 2022-04-29 2023-03-30 West Bengal Chemical Industries Limited Pharmaceutical acceptable iron (iii) coordination complex having high phosphate binding capacity and preparation thereof
KR102623739B1 (ko) * 2022-07-28 2024-01-11 주식회사 페라메드 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335218B (en) * 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US8093423B2 (en) * 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
JP4931352B2 (ja) * 2004-01-14 2012-05-16 月桂冠株式会社 鉄補給剤及びその利用
CA2552889A1 (en) * 2004-01-14 2005-07-28 Sachiko Suzuki Iron supplement and utilization of the same
NZ566743A (en) * 2005-08-18 2010-07-30 Globoasia Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
WO2012097155A1 (en) * 2011-01-14 2012-07-19 Chiasma Inc. Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
SG11201408521WA (en) * 2012-06-21 2015-01-29 Keryx Biopharmaceuticals Inc Use of ferric citrate in the treatment of chronic kidney disease patients

Also Published As

Publication number Publication date
HK1246649A1 (zh) 2018-09-14
TW202302083A (zh) 2023-01-16
JP2018507260A (ja) 2018-03-15
KR20170123664A (ko) 2017-11-08
WO2016141124A1 (en) 2016-09-09
CN107530310A (zh) 2018-01-02
BR112017018963A2 (pt) 2018-05-15
EP3265077A1 (en) 2018-01-10
EP3265077A4 (en) 2018-10-24
TW201639558A (zh) 2016-11-16
TWI812580B (zh) 2023-08-21
EA201791960A1 (ru) 2018-01-31
US20240075006A1 (en) 2024-03-07
SG11201707120PA (en) 2017-09-28
CA2978073A1 (en) 2016-09-09
MX2017011169A (es) 2017-11-09
JP2021091686A (ja) 2021-06-17
AU2016226250A1 (en) 2017-09-28
IL254125A0 (en) 2017-10-31
US20180071243A1 (en) 2018-03-15
AU2016226250B2 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
AU2018203205B2 (en) Use of ferric citrate in the treatment of chronic kidney disease patients
TWI812580B (zh) 檸檬酸鐵用於治療缺鐵性貧血之用途
JP6828100B2 (ja) 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
JPWO2019059172A1 (ja) 過多月経患者及び/又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び/又は治療におけるクエン酸第二鉄の使用
US20190269645A1 (en) Use of ferric citrate in the treatment of chronic kidney disease patients
CN102961559A (zh) 云南白药作为治疗骨癌痛药物的应用